DE1113937B - Process for the preparation of heterocyclic amides of phosphoric acid - Google Patents
Process for the preparation of heterocyclic amides of phosphoric acidInfo
- Publication number
- DE1113937B DE1113937B DES65826A DES0065826A DE1113937B DE 1113937 B DE1113937 B DE 1113937B DE S65826 A DES65826 A DE S65826A DE S0065826 A DES0065826 A DE S0065826A DE 1113937 B DE1113937 B DE 1113937B
- Authority
- DE
- Germany
- Prior art keywords
- phosphoric acid
- acid
- carbonyl
- heterocyclic
- amides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 title claims description 60
- 229910000147 aluminium phosphate Inorganic materials 0.000 title claims description 24
- -1 heterocyclic amides Chemical class 0.000 title claims description 20
- 238000000034 method Methods 0.000 title claims description 9
- 238000002360 preparation method Methods 0.000 title claims description 4
- 235000011007 phosphoric acid Nutrition 0.000 claims description 33
- 150000005690 diesters Chemical class 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 229910017464 nitrogen compound Inorganic materials 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 17
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 7
- JBFYUZGYRGXSFL-UHFFFAOYSA-N imidazolide Chemical compound C1=C[N-]C=N1 JBFYUZGYRGXSFL-UHFFFAOYSA-N 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 4
- 150000004693 imidazolium salts Chemical class 0.000 description 4
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- ASMQGLCHMVWBQR-UHFFFAOYSA-N Diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)(O)OC1=CC=CC=C1 ASMQGLCHMVWBQR-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- YTFJQDNGSQJFNA-UHFFFAOYSA-N benzyl dihydrogen phosphate Chemical compound OP(O)(=O)OCC1=CC=CC=C1 YTFJQDNGSQJFNA-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- BBAMTDMNXVSCRU-UHFFFAOYSA-N (4-chlorophenyl) dihydrogen phosphate Chemical compound OP(O)(=O)OC1=CC=C(Cl)C=C1 BBAMTDMNXVSCRU-UHFFFAOYSA-N 0.000 description 2
- GKGYYUQEALMKIF-UHFFFAOYSA-N (5-methyl-2-propan-2-ylphenyl) dihydrogen phosphate Chemical compound CC(C)C1=CC=C(C)C=C1OP(O)(O)=O GKGYYUQEALMKIF-UHFFFAOYSA-N 0.000 description 2
- XLSZMDLNRCVEIJ-UHFFFAOYSA-N 4-methylimidazole Chemical compound CC1=CNC=N1 XLSZMDLNRCVEIJ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 150000007928 imidazolide derivatives Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- OQKIXVMPYSZBCB-UHFFFAOYSA-N (4-nitrophenyl)methyl dihydrogen phosphate Chemical compound OP(O)(=O)OCC1=CC=C([N+]([O-])=O)C=C1 OQKIXVMPYSZBCB-UHFFFAOYSA-N 0.000 description 1
- CFGDUGSIBUXRMR-UHFFFAOYSA-N 1,2-dihydropyrrol-2-ide Chemical compound C=1C=[C-]NC=1 CFGDUGSIBUXRMR-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- ZSIAANIILFGLQH-UHFFFAOYSA-N C1(=CC=CC=C1)[ClH]P(=O)(Cl)[ClH]C1=CC=CC=C1 Chemical compound C1(=CC=CC=C1)[ClH]P(=O)(Cl)[ClH]C1=CC=CC=C1 ZSIAANIILFGLQH-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- HDFFVHSMHLDSLO-UHFFFAOYSA-N Dibenzyl phosphate Chemical compound C=1C=CC=CC=1COP(=O)(O)OCC1=CC=CC=C1 HDFFVHSMHLDSLO-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- PGPAMLREPDTQCG-UHFFFAOYSA-N bis(1,2,3-triphenylimidazol-2-yl)methanone Chemical compound C(=O)(C1(N(C=CN1C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=CC=C1)C1(N(C=CN1C1=CC=CC=C1)C1=CC=CC=C1)C1=CC=CC=C1 PGPAMLREPDTQCG-UHFFFAOYSA-N 0.000 description 1
- VRAVWQUXPCWGSU-UHFFFAOYSA-N bis(1h-1,2,4-triazol-5-yl)methanone Chemical compound N1=CNN=C1C(=O)C=1N=CNN=1 VRAVWQUXPCWGSU-UHFFFAOYSA-N 0.000 description 1
- GRSTVVGJSKHCCS-UHFFFAOYSA-N bis(1h-imidazol-2-yl)methanone Chemical compound N=1C=CNC=1C(=O)C1=NC=CN1 GRSTVVGJSKHCCS-UHFFFAOYSA-N 0.000 description 1
- OJKZEZMAPKWHTG-UHFFFAOYSA-N bis(2h-triazol-4-yl)methanone Chemical compound C=1NN=NC=1C(=O)C1=CNN=N1 OJKZEZMAPKWHTG-UHFFFAOYSA-N 0.000 description 1
- DUYAPABVVRDPSP-UHFFFAOYSA-N bis(3,5-dimethyl-1H-pyrazol-4-yl)methanone Chemical compound C(=O)(C=1C(=NNC1C)C)C=1C(=NNC1C)C DUYAPABVVRDPSP-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- AKAUCGJQKLOHHK-UHFFFAOYSA-N cyclohexyl dihydrogen phosphate Chemical compound OP(O)(=O)OC1CCCCC1 AKAUCGJQKLOHHK-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 150000001470 diamides Chemical class 0.000 description 1
- YQHVEGTZGGQQMV-UHFFFAOYSA-N dicyclohexyl hydrogen phosphate Chemical compound C1CCCCC1OP(=O)(O)OC1CCCCC1 YQHVEGTZGGQQMV-UHFFFAOYSA-N 0.000 description 1
- UCQFCFPECQILOL-UHFFFAOYSA-N diethyl hydrogen phosphate Chemical compound CCOP(O)(=O)OCC UCQFCFPECQILOL-UHFFFAOYSA-N 0.000 description 1
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 150000003012 phosphoric acid amides Chemical class 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- ITNARJVABSUAAM-UHFFFAOYSA-N propan-2-one;2h-triazole Chemical compound CC(C)=O.C=1C=NNN=1 ITNARJVABSUAAM-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/02—Phosphorylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/08—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents
- C07K1/082—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents containing phosphorus
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Saccharide Compounds (AREA)
Description
DEUTSCHESGERMAN
PATENTAMTPATENT OFFICE
S 65826 IVd/12pS 65826 IVd / 12p
BEKANNTMACHUNG DER ANMELDUNG UND AUSGABE DER AUSLEGESCHRIFT: 21. SEPTEMBER 1961NOTICE THE REGISTRATION AND ISSUE OF THE EDITORIAL: SEPTEMBER 21, 1961
Die Erfindung betrifft ein Verfahren zur Herstellung von heterocyclischen Amiden der Phosphorsäure.The invention relates to a process for the preparation of heterocyclic amides of phosphoric acid.
Es ist bekannt (siehe J. Chem. Soc, 1956, S. 2812), daß ein wichtiger Vertreter dieser Klasse von Verbindungen, nämlich das Phosphorsäurediesterimidazolid, sich bildet, wenn man Diphenylphosphorsäurechlorid mit Imidazol umsetzt; jedoch wurde die Substanz nicht isoliert, sondern in Lösung weiterverarbeitet. Dieses Verfahren hat für die Darstellung von Phosphorsäurediesterimidazoliden den Nachteil, daß man von Phosphorsäurediesterchloriden ausgehen muß, die sich bei empfindlichen Estern der Phosphorsäure, wie z. B. Zuckerphosphaten und biologisch wichtigen Phosphaten, nicht darstellen lassen. In Chem. Abstracts, 50 (1956), S. ρ 10826 g, und 51 (1957), S. ρ 3702 i, werden Arbeiten von Rathiev und Rosenberg referiert, wobei bei einer Reaktion zwischen Aminophosphat und Imidazol teilweise Phosphorylierung des Stickstoffs stattfindet. Weiter ist in einer Publikation in Angew. Chemie, 71 (1959), S. 195, berichtet worden, daß NN'-Carbonyldi-imidazol (leicht herzustellen aus Phosgen und Imidazol nach der deutschen Patentschrift 1033 210) mit Carbonsäuren zu Imidazoliden umgesetzt werden kann.It is known (see J. Chem. Soc, 1956, p. 2812) that an important representative of this class of compounds, namely the phosphoric acid diesterimidazolide, is formed when diphenylphosphoric acid chloride Reacts with imidazole; however, the substance was not isolated, but processed further in solution. This method has for the preparation of phosphoric acid diesterimidazolides Disadvantage that you have to start from phosphoric acid diester chlorides, which are the sensitive esters Phosphoric acid, e.g. B. sugar phosphates and biologically important phosphates do not represent permit. In Chem. Abstracts, 50 (1956), p. Ρ 10826 g, and 51 (1957), p. Ρ 3702 i, works by Rathiev and Rosenberg gave a lecture, with a reaction between aminophosphate and imidazole partial phosphorylation of nitrogen takes place. Furthermore, in a publication in Angew. Chemistry, 71 (1959), p. 195, it has been reported that NN'-carbonyldi-imidazole (easy to manufacture from phosgene and imidazole according to German patent specification 1033 210) with Carboxylic acids can be converted to imidazolides.
Das Ziel der Erfindung ist nun, heterocyclische Amide der Phosphorsäure herzustellen unter Anwendung von NN'-Carbonylderivaten von fünfgliedrigen ungesättigten heterocyclischen — sogenannten quasi aromatischen — Stickstoffverbindungen mit mindestens zwei Ringstickstoffatomen und deren Substitutionsprodukten als Reaktionskomponenten. The object of the invention is now to produce heterocyclic amides of phosphoric acid using of NN'-carbonyl derivatives of five-membered unsaturated heterocyclic - so-called quasi aromatic - nitrogen compounds with at least two ring nitrogen atoms and their substitution products as reaction components.
Es ist nunmehr gefunden worden, daß man heterocyclische Amide der Phosphorsäure herstellen kann durch Reaktion der obengenannten NN'-Carbonyl-Verbindungen mit Orthophosphorsäure oder deren Mono- und Diestern. Als Beispiele dieser NN'-Carbonylverbindungen können genannt werden: Carbonyl-di-imidazol, Carbonyl-di-(4 oder 5-methyl-imidazol), Carbonyl-di-(triphenyl-imidazol), Carbonyl-di-1,2,3-triazol, Carbonyl-di-(l,2,4-triazol), Carbonyl-dibenzimidazol, Carbonyl-dibenz-1,2,3-triazol, Carbonyldi-(3,5-dimethyl-pyrazol). Als Beispiele für die Mono- und Diester der Orthophosphorsäure seien genannt: Benzylphosphorsäure, p-Nitrobenzylphosphorsäure, Adenosinphosphorsäure, Cyclohexylphosphorsaure, Diphenylphosphorsäure und deren kernsubstituierte Derivate, Dibenzylphosphorsäure, Di-p-nitrobenzylphosphorsäure, Diäthylphosphorsäure, Dicyclohexylphosphorsäure. It has now been found that heterocyclic amides of phosphoric acid can be prepared by reaction of the above-mentioned NN'-carbonyl compounds with orthophosphoric acid or its mono- and diesters. As examples of these NN'-carbonyl compounds can be mentioned: carbonyl-di-imidazole, carbonyl-di- (4 or 5-methyl-imidazole), Carbonyl-di- (triphenyl-imidazole), carbonyl-di-1,2,3-triazole, carbonyl-di- (1,2,4-triazole), carbonyl-dibenzimidazole, Carbonyl-dibenz-1,2,3-triazole, carbonyldi- (3,5-dimethyl-pyrazole). As examples of the mono- and diesters of orthophosphoric acid may be mentioned: benzylphosphoric acid, p-nitrobenzylphosphoric acid, Adenosine phosphoric acid, cyclohexyl phosphoric acid, diphenyl phosphoric acid and their ring-substituted ones Derivatives, dibenzyl phosphoric acid, di-p-nitrobenzyl phosphoric acid, Diethyl phosphoric acid, dicyclohexyl phosphoric acid.
Formelmäßig kann man die Reaktion am Beispiel der Imidazolverbindung wie folgt darstellen:In terms of formula, the reaction can be represented as follows using the example of the imidazole compound:
Verfahren zur HerstellungMethod of manufacture
von heterocyclischen Amidenof heterocyclic amides
der Phosphorsäureof phosphoric acid
Anmelder:Applicant:
Shell Internationale Research Maatschappij N. V., Den HaagShell Internationale Research Maatschappij N.V., The Hague
Vertreter: Dr.-Ing. F. Wuesthoff, Dipl.-Ing. G. Puls und DipL-Chem. Dr. rer. nat. E. Frhr. v. Pechmann, Patentanwälte, München 9, Schweigerstr. 2Representative: Dr.-Ing. F. Wuesthoff, Dipl.-Ing. G. Pulse and DipL-Chem. Dr. rer. nat. E. Frhr. v. Pechmann, patent attorneys, Munich 9, Schweigerstr. 2
N N— C—N N + HO —N N— C — N N + HO -
,OR1 OR2 , OR 1 OR 2
,OR1 , OR 1
ν ν—ρ;ν ν-ρ;
4- CO2 + HN N4- CO 2 + HN N
-OR,-OR,
worin R1 und R2 Wasserstoff, Alkyl, Aryl, Aralkyl, Cycloalkyl oder Nucleotidrest darstellen.wherein R 1 and R 2 represent hydrogen, alkyl, aryl, aralkyl, cycloalkyl or nucleotide radicals.
Die erfindungsgemäßen heterocyclischen Amide der Phosphorsäure kann man in drei Typen darstellen, und zwar unveresterte Phosphorsäureamide der FormelThe heterocyclic amides of phosphoric acid according to the invention can be represented in three types, namely unesterified phosphoric acid amides of the formula
N-N-
-P-OH-P-OH
OHOH
Phosphorsäure-monoester-amide der FormelPhosphoric acid monoester amides of the formula
N-P-OR1 OHNP-OR 1 OH
109 689/225109 689/225
und Phosphorsäure-diester-amide der Formel stürmisch mit Butylamin und wurde auf diese Weiseand phosphoric acid diester amides of the formula blended with butylamine and was made in this way
charakterisiert.characterized.
0 Beispiel 2 0 example 2
j ρ Qj^ 5 Monophenylphosphorsäure-imidazolidj ρ Qj ^ 5 monophenylphosphoric acid imidazolide
3,05 g Monophenylphosphorsäure wurden in 3 cm3 OR2 Acetonitril und 10 cm3 Benzol gelöst und 3,5 g Car-3.05 g of monophenyl phosphoric acid were dissolved in 3 cm 3 of OR 2 acetonitrile and 10 cm 3 of benzene and 3.5 g of car-
bonyldiimidazol hinzugefügt. Nach 15 Minuten beibonyldiimidazole added. After 15 minutes at
worin R1 und R2 die obengenannte Bedeutung und Raumtemperatur war die CO2-Entwicklung beendet.where R 1 and R 2 have the abovementioned meaning and room temperature, the evolution of CO 2 ceased.
ίο Es wurde noch kurz zum Sieden erhitzt, abgekühlt und 5 cm3 Cyclohexylamin, 0,2 cm3 Wasser undίο It was briefly heated to boiling, cooled and 5 cm 3 of cyclohexylamine, 0.2 cm 3 of water and
N— 30 cm3 Äther hinzugefügt. Die nicht umgesetzteN— 30 cm 3 of ether added. The one not implemented
Monophenylphosphorsäure kristallisierte in der Kälte aus (Cyclohexylammoniumsalz 0,75 g). Es wurde der heterocyclische Rest der oben gegebenen 15 filtriert, das Filtrat im Vakuum eingedampft, das Definition entspricht. Wenn R1 und/oder R2 Wasser- zurückbleibende Öl in 50 cm3 Aceton aufgenommen stoff darstellen, ist es möglich, daß ein zweites Molekül und mit 50 cm3 Äther versetzt. Nach 2 Stunden bei der NN'-Carbonylverbindung mit einer der Hydroxyl- 00C waren 4,45 g (79% der Theorie) an Cyclohexylgruppen weiterreagiert unter Bildung von hetero- ammoniumsalz des Monophenylphosphorsäure-imidcyclischen Diamiden der Formel 20 azolids auskristallisiert. Schmp. 1150C. Die SubstanzMonophenylphosphoric acid crystallized out in the cold (cyclohexylammonium salt 0.75 g). The heterocyclic residue of the 15 given above was filtered and the filtrate was evaporated in vacuo, which corresponds to the definition. If R 1 and / or R 2 represent water remaining oil taken up in 50 cm 3 of acetone, it is possible that a second molecule and mixed with 50 cm 3 of ether. After 2 hours at the N, N'-carbonyl compound with one of the hydroxyl 0 0 C were 4.45 g (79% of theory) reacts further to cyclohexyl groups to form hetero- ammonium salt of Monophenylphosphorsäure-imidcyclischen diamides of the formula 20 azolide crystallized. Mp. 115 0 C. The substance
ist leicht löslich in Wasser und hydrolysiert im Verlauf O von einigen Tagen, schwer löslich in Pyridin, Aceton,is easily soluble in water and hydrolyzes in the course O of a few days, sparingly soluble in pyridine, acetone,
0 Äther, Benzol.0 ether, benzene.
25 Beispiel 3 2 5 Example 3
O Rj, 2 Diimidazolid der OrthophosphorsäureO Rj, 2 diimidazolide of orthophosphoric acid
Wasserfreie Orthophosphorsäure wurde mit 2 MolAnhydrous orthophosphoric acid was with 2 mol
Die nach der Erfindung hergestellten Verbindungen Carbonyldiimidazol in Dimethylformamid bei Raumsind
sehr reaktionsfähig und können mit Alkoholen 30 temperatur umgesetzt. Es entwickelte sich stürmisch
zu Estern mit Aminen zu Amiden und mit Säuren zu CO2, und die Imidazoliumsalze der Phosphorsäuren
Anhydriden der Phosphorsäure umgesetzt werden. fielen aus. Sie enthielten das Phosphorsäurediimid-Die
heterocyclischen Amide der Phosphorsäure sind azolid, welches direkt für weitere Reaktionen einge-Öle
bis kristallisierte Verbindungen, die nach der setzt werden kann, z. B. reagiert es mit Alkoholen zu
oben angegebenen Reaktionsgleichung in 70 bis 90% 35 Diestern.
der Theorie entstehen. Diese Verbindungen werdenThe compounds produced according to the invention, carbonyldiimidazole in dimethylformamide at room temperature, are very reactive and can be reacted with alcohols at 30 temperature. It developed rapidly to esters with amines to amides and with acids to CO 2 , and the imidazolium salts of phosphoric acids anhydrides of phosphoric acid are converted. failed. They contained the phosphoric acid diimide-The heterocyclic amides of phosphoric acid are azolid, which is used directly for further reactions. B. it reacts with alcohols to the reaction equation given above in 70 to 90% 35 diesters.
the theory arise. These connections will
vorzugsweise in Form ihrer Salze isoliert und sind in Beispiel 4preferably isolated in the form of their salts and are in Example 4
dieser Form haltbar. _, . ., ,.,,,, , , , , durable in this form. _,. .,. ,,,,,,,,
Die heterocyclischen Amide der Phosphorsäure Monoimidazohd der MonobenzylphosphorsaureThe heterocyclic amides of phosphoric acid Monoimidazohd of monobenzylphosphoric acid
können mittels Reaktion mit Phosphorsäure, Phos- 4° 528 mg Monobenzylphosphorsaure wurden in 8 cm3 can by reaction with phosphoric acid, Phos- 4 ° 528 mg monobenzylphosphoric acid were in 8 cm 3
phorsäuremonoester oder-diester zu den entsprechen- Tetrahydrofuran gelöst und 502 mg Carbonyldi-phosphoric acid monoester or diester dissolved to the corresponding tetrahydrofuran and 502 mg carbonyl diester
den Pyrophosphaten in nahezu quantitativer Ausbeute imidazol zugegeben. Nach 10 Minuten war die stür-added imidazole to the pyrophosphates in almost quantitative yield. After 10 minutes the stormy
umgesetzt werden. Diese Reaktionen sind deswegen mische CO2-Entwicklung beendet, Gewichtsverlustimplemented. These reactions are therefore terminated mixed CO 2 evolution, weight loss
besonders interessant, weil sie präparativ in viel- 110 mg CO2. Das Lösungsmittel wurde im Vakuumparticularly interesting because they are preparatively in a lot of 110 mg CO 2 . The solvent was in vacuo
fältiger Weise die Synthese von Coenzymen und ahn- 45 weggedampft, das zurückbleibende Öl mit 25 cm3 Wrong way the synthesis of coenzymes and evaporated away, the remaining oil with 25 cm 3
liehen Verbindungen ermöglichen sollen. Auch ist es Aceton aufgenommen und in der Kälte mit 0,2 cm3 should allow borrowed connections. It is also absorbed by acetone and in the cold with 0.2 cm 3
bei diesem Verfahren besonders vorteilhaft, daß man Wasser, 1 cm3 Cyclohexylamin und 25 cm3 Ätherin this process it is particularly advantageous that water, 1 cm 3 of cyclohexylamine and 25 cm 3 of ether
reine unsymmetrische Pyrophosphate erhalten kann, versetzt. Nach 12 Stunden bei 00C waren 580 mg descan obtain pure asymmetrical pyrophosphates, added. After 12 hours at 0 ° C., 580 mg des
was bei den bisher bekannten Methoden meistens Imidazolids als Cyclohexylammoniumsalz auskristalli-which in the previously known methods usually imidazolide crystallizes out as the cyclohexylammonium salt
nicht ohne weiteres möglich ist. 50 siert, Ausbeute: 60% der Theorie; Fp. 112°C; Lös-is not easily possible. 50%, yield: 60% of theory; Mp 112 ° C; Loosening
Die erfindungsgemäßen Verbindungen reagieren lichkeitseigenschaften wie beim Monophenylderivat. mit Carbonsäuren zu Phosphorsäure-carbonsäure-The compounds according to the invention react like the monophenyl derivative. with carboxylic acids to form phosphoric acid carboxylic acid
anhydriden, welche sich z. B. als milde AcyHerungsmittel Beispiel 5anhydrides, which z. B. As a mild acetic agent Example 5
besonders für die Peptidsynthese eignen. _, . ., ,., , _,. , . , ,particularly suitable for peptide synthesis. _,. .,,.,, _ ,. ,. ,,
Monoimidazohd der p-ChlorphenylphosphorsaureMonoimidazohd of p-chlorophenylphosphoric acid
Beispiel 1 415 mg p-Chlorphenylphosphorsäure wurden inExample 1 415 mg of p-chlorophenylphosphoric acid were in
■n. , - 1 ■. , .. . ., f, 8 cm3 Benzol und 2 cm3 Acetonitril gelöst und 340 mg ■ n. , - 1 ■. , ... ., f , 8 cm 3 of benzene and 2 cm 3 of acetonitrile dissolved and 340 mg
Diphenylphosphorsaure-imidazolid Carbonyldümidazol zugegeben. Nach 10 Minuten (EndeDiphenylphosphoric acid imidazolide carbonyldümidazole added. After 10 minutes (end
2 Mol Diphenylphosphorsäure und 1 Mol Carbonyl- der Gasentwicklung) wurde im Vakuum eingeengt,2 moles of diphenylphosphoric acid and 1 mole of carbonyl gas evolution) was concentrated in vacuo,
diimidazol wurden in einem verschlossenen Kolben 60 Das zurückgebliebene Öl erstarrte nach 12 Stundendiimidazole were placed in a sealed flask. The remaining oil solidified after 12 hours
mit Calciumchloridrohr zusammengegeben und auf bei 00C und wurde aus Aceton—Äther umkristallisiert,combined with calcium chloride tube and at 0 0 C and was recrystallized from acetone-ether,
dem Wasserbad erwärmt. Ab 500C tritt stürmische Ausbeute: 438 mg (67% der Theorie); Fp. 87°C.
CO2-Entwicklung auf, und 75% der Theorie an CO2 warmed up in the water bath. From 50 0 C there is a stormy yield: 438 mg (67% of theory); Mp 87 ° C.
CO 2 evolution and 75% of theory CO 2
entweichen. Der Rückstand wurde in Tetrahydrofuran Beispiel 6escape. The residue was dissolved in tetrahydrofuran Example 6
aufgenommen, wobei der größte Teil des Imidazoüum- 65 ..,-■,.,■■ o-^r ■,-,-, ιrecorded, with most of the imidazoüum- 65 .., - ■,., ■■ o - ^ r ■, -, -, ι
salzes ungelöst zurückbleibt. Beim Abdestülieren des Monoimidazohd der ^-Naphtylphosphorsauresalt remains undissolved. When distilling off the Monoimidazohd der ^ -Naphtylphosphorsaure
Tetrahydrofurans im Vakuum hinterblieb das Di- 450 mg ß-Naphtylphosphorsäure wurden in 5 cm3 Tetrahydrofuran remained behind in vacuo, the di- 450 mg of ß-naphthylphosphoric acid were in 5 cm 3
phenylphosphorylimidazol als ein Öl. Es reagierte Tetrahydrofuran gelöst und 345 mg Carbonyldiimid-phenylphosphorylimidazole as an oil. It reacted dissolved tetrahydrofuran and 345 mg carbonyldiimide
azol zugegeben. Nach Beendigung der Gasentwicklung wurde im Vakuum eingedampft, mit Aceton aufgenommen und dann 0,2 cm3 Wasser und 500 mg Natriumiodid, in Aceton gelöst, zugesetzt. Das sofort ausfallende Natriumsalz des Imidazolids wurde aus Wasser—Aceton umkristallisiert. Ausbeute: 422 mg (71 % der Theorie); Fp. > 250°C.azole added. After the evolution of gas had ceased, the mixture was evaporated in vacuo, taken up in acetone and then 0.2 cm 3 of water and 500 mg of sodium iodide, dissolved in acetone, were added. The immediately precipitating sodium salt of the imidazolide was recrystallized from water-acetone. Yield: 422 mg (71% of theory); Mp> 250 ° C.
Monoimidazolid der Monomethylglykolphosphorsäure Monoimidazolide of monomethylglycol phosphoric acid
246 mg der Säure wurden in 4 cm3 Tetrahydrofuran gelöst und 120 mg Imidazol sowie anschließend 308 mg Carbonyldiimidazol zugegeben. Der Gewichtsverlust durch CO2-Entwicklung betrug nach 15 Minuten 71 mg. Das entstandene Imidazolid wurde wie bei Beispiel 4 als Cyclohexylammoniumsalz isoliert. Ausbeute: 295 mg (56% der Theorie); Fp. 126°C.246 mg of the acid were dissolved in 4 cm 3 of tetrahydrofuran and 120 mg of imidazole and then 308 mg of carbonyldiimidazole were added. The weight loss due to the evolution of CO 2 was 71 mg after 15 minutes. The resulting imidazolide was isolated as in Example 4 as the cyclohexylammonium salt. Yield: 295 mg (56% of theory); Mp 126 ° C.
Beispiel 8
Monoimidazolid der MonothymylphosphorsäureExample 8
Monoimidazolide of monothymyl phosphoric acid
589 mg Monothymylphosphorsäure in 8 cm3 Tetrahydrofuran wurden mit 280 mg Carbonyldiimidazol versetzt und nach Beendigung der CO2-Entwicklung (85 mg CO2) im Vakuum eingedampft. Der Rückstand wurde aus 2 cm3 Acetonitril umkristallisiert und das Imidazolid analysenrein erhalten. Ausbeute: 736 mg Imidazoliumsalz (82% der Theorie); Fp. 91°C. Die Substanz ist sehr hygroskopisch und leicht löslich in polaren Lösungsmitteln, wie Wasser, Aceton, Pyridin, schwer löslich in unpolaren Lösungsmitteln, wie Benzol und Äther.589 mg of monothymylphosphoric acid in 8 cm 3 of tetrahydrofuran were mixed with 280 mg of carbonyldiimidazole and, after the evolution of CO 2 (85 mg of CO 2 ) had ended, the mixture was evaporated in vacuo. The residue was recrystallized from 2 cm 3 of acetonitrile and the imidazolide was obtained in analytically pure form. Yield: 736 mg of the imidazolium salt (82% of theory); Mp 91 ° C. The substance is very hygroscopic and easily soluble in polar solvents such as water, acetone, pyridine, and poorly soluble in non-polar solvents such as benzene and ether.
Beispiel 9
Monoimidazolid der OrthophosphorsäureExample 9
Monoimidazolide of orthophosphoric acid
310 mg Orthophosphorsäure wurden in 3 cm3 Dimethylformamid gelöst und 500 mg Carbonyldiimidazol zugegeben. Es entwickelte sich stürmisch CO2, die Imidazoliumsalze der Phosphorsäuren fielen aus. Durch Umkristallisation aus Wasser—Aceton wurde das Imidazoliumsalz des Imidazolids rein erhalten. Ausbeute: 362 mg (54% der Theorie); Fp. 164°C.310 mg of orthophosphoric acid were dissolved in 3 cm 3 of dimethylformamide and 500 mg of carbonyldiimidazole were added. There was a stormy development of CO 2 , and the imidazolium salts of phosphoric acids precipitated. The imidazolium salt of the imidazolide was obtained in pure form by recrystallization from water-acetone. Yield: 362 mg (54% of theory); Mp 164 ° C.
Beispiel 10
Natriumsalz des PhenylphosphorsäurebenztriazolidsExample 10
Phenylphosphoric acid benzotriazolide sodium salt
Zur Lösung von 0,9 g (0,5 niM) Phenylphosphorsäure und 2,5 ml (1,8 mM) Triäthylamin in 10 ml absolutem Aceton fügt man 1,7 g (0,65 mM) Carbonyldibenz-l,2,3-triazol hinzu und läßt unter häufigem Umschütteln etwa V2 Stunde bei Zimmertemperatur stehen. Danach erhitzt man kurze Zeit zum Sieden, läßt abkühlen und verdünnt mit 30 ml Aceton. Das Na-SaIz fällt man mit der Lösung von 1 g NaJ in ml Aceton als amorphen Niederschlag aus, filtriert ab, wäscht sehr gut nach und trocknet schließlich im Vakuum oder auf Ton. Löslich in H2O, Alkohol und Dimethylformamid, unlöslich in Aceton, Chloroform und Pyridin.1.7 g (0.65 mM) carbonyldibenz-1,2,3 are added to the solution of 0.9 g (0.5 niM) phenylphosphoric acid and 2.5 ml (1.8 mM) triethylamine in 10 ml absolute acetone -triazole added and left to stand for about 2 hours at room temperature with frequent shaking. The mixture is then heated to the boil for a short time, allowed to cool and diluted with 30 ml of acetone. The sodium salt is precipitated as an amorphous precipitate with the solution of 1 g of NaI in ml of acetone, filtered off, washed very well and finally dried in vacuo or on clay. Soluble in H 2 O, alcohol and dimethylformamide, insoluble in acetone, chloroform and pyridine.
Ausbeute: chromatographisch über 90%, isoliert %. Die Substanz gibt die gleichen Reaktionen wie die anderen Phosphorsäureimidazolide.Yield: chromatographically over 90%, isolated%. The substance gives the same reactions as the other phosphoric imidazolides.
Analyse des Natriumsalzes C12H9N3O3PNa:
Berechnet ... C 48,50, H 3,05, N 14,14, P 10,42; gefunden ... C 47,98, H 2,96, N 13,89, P 9,67.Analysis of the sodium salt C 12 H 9 N 3 O 3 PNa:
Calculated ... C 48.50, H 3.05, N 14.14, P 10.42; Found ... C 47.98, H 2.96, N 13.89, P 9.67.
Claims (3)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DES65826A DE1113937B (en) | 1959-11-13 | 1959-11-13 | Process for the preparation of heterocyclic amides of phosphoric acid |
FR843700A FR1273603A (en) | 1959-11-13 | 1960-11-10 | Process for the preparation of heterocyclic amides of phosphoric acid |
GB38800/60A GB950290A (en) | 1959-11-13 | 1960-11-11 | Improvements in or relating to a process for the preparation of heterocyclic phosporic acid amides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DES65826A DE1113937B (en) | 1959-11-13 | 1959-11-13 | Process for the preparation of heterocyclic amides of phosphoric acid |
Publications (1)
Publication Number | Publication Date |
---|---|
DE1113937B true DE1113937B (en) | 1961-09-21 |
Family
ID=7498334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DES65826A Pending DE1113937B (en) | 1959-11-13 | 1959-11-13 | Process for the preparation of heterocyclic amides of phosphoric acid |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE1113937B (en) |
GB (1) | GB950290A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0035719A2 (en) * | 1980-02-29 | 1981-09-16 | University Patents, Inc. | Process for producing modified inorganic polymers, their use in producing polynucleotides, and a reagent useful in these processes |
-
1959
- 1959-11-13 DE DES65826A patent/DE1113937B/en active Pending
-
1960
- 1960-11-11 GB GB38800/60A patent/GB950290A/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0035719A2 (en) * | 1980-02-29 | 1981-09-16 | University Patents, Inc. | Process for producing modified inorganic polymers, their use in producing polynucleotides, and a reagent useful in these processes |
EP0035719B1 (en) * | 1980-02-29 | 1989-09-20 | University Patents, Inc. | Process for producing modified inorganic polymers, their use in producing polynucleotides, and a reagent useful in these processes |
Also Published As
Publication number | Publication date |
---|---|
GB950290A (en) | 1964-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1795763A1 (en) | PROCESS FOR THE PRODUCTION OF DESACYLATED NUCLEAR INDOLE COMPOUNDS AND THEIR ESTERS | |
DE1962757C3 (en) | Evomonoside derivatives, processes for their production and pharmaceuticals containing them | |
DE1113937B (en) | Process for the preparation of heterocyclic amides of phosphoric acid | |
DE4030587C2 (en) | Process for the preparation of D-myoinosit-1-phosphate | |
DE3150288C2 (en) | ||
DE3152632C2 (en) | 3- [3- (2-chloroethyl) -ureido] -3-deoxy-1,2,5,6-di-O-isopropylidene-α-D-allofuranose, process for its preparation and its use | |
EP0306868B1 (en) | Process for the preparation of 1-alkyl imidazoles | |
CH670091A5 (en) | ||
DE2005959A1 (en) | 7-Nitro-8-hydroxyquinoline esters, their use and process for the preparation thereof | |
DE4222910A1 (en) | New phospholipid derivatives | |
EP0078949B1 (en) | 1-furyl-3,4-dihydroisoquinolines, process for their preparation, their use and medicines containing them | |
EP1950196A1 (en) | Method for manufacturing ammonium hexafluorphosphates | |
DE69129399T2 (en) | Phosphorylating agents and methods of forming an asymmetric phosphodiester bond using the same agent | |
DE1795701B2 (en) | ALPHA-SUBSTITUTED BENZYL PENICILLIC ACID ESTERS | |
CH497413A (en) | Proscillaridin a derivs | |
DE948687C (en) | Process for the production of dialkylxanthine capsules | |
DE60204721T2 (en) | PREPARATION OF CRYSTALLINE POLYMORPHS OF FOSINOPRIL SODIUM | |
DE102009052034A1 (en) | Synthesis of phosphorus esters | |
DE1545838C3 (en) | 7- (2-Azidooctanamido) -cephalosporanic acid, its salts and process for the preparation of these compounds | |
AT371804B (en) | METHOD FOR PRODUCING S-METHYL-METHIONINE SULFONIUM SALTS | |
DE2411904C3 (en) | Process for the preparation of β-bromocarboxamides | |
EP0087656B1 (en) | Process for the preparation of 1-(4-chlorbenzoyl)-5-methoxy-2-methyl-3-indolylacetoxy-acetic acid | |
EP0594999A1 (en) | Phospholipid derivatives containing higher elements of the fifth main group | |
AT246921B (en) | Process for the production of penicillins | |
AT277474B (en) | Process for the preparation of new derivatives of bufadienolide glycosides |